Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine

BJOG : an International Journal of Obstetrics and Gynaecology
R M Freeman

Abstract

Stress urinary incontinence (SUI) is common among women of all ages and can have a negative impact on quality of life (QoL). Often, women refrain from seeking treatment due to the fear that surgery might be the only option, or that no other treatments exist. SUI symptoms can often be treated with simple measures such as pelvic floor muscle training (PFMT), weight loss, devices, etc. However, PFMT has low compliance rates, and few continue long term. More recently, another treatment option has been introduced, i.e. the relatively balanced serotonin and noradrenaline reuptake inhibitor (SNRI) duloxetine. PFMT and/or SNRI are recommended as a first-line therapy for the initial management of SUI in women in the guidelines of the third International Consultation on Incontinence. SNRI have received a grade A recommendation. As PFMT and duloxetine target different areas (i.e. pelvic floor muscle and distal urethral sphincter/rhabdosphincter, respectively), combined therapy might provide additional benefit. A recent study comparing the effect of combined treatment with no active treatment found that combination therapy was significantly better for all outcomes, including frequency of SUI episodes, pad use, improvements in QoL and globa...Continue Reading

References

Jul 22, 1998·Journal of the American Geriatrics Society·J M MillerJ O DeLancey
May 2, 2001·The Cochrane Database of Systematic Reviews·E J Hay-SmithE S van Waalwijk van Doorn
May 11, 2001·Health Education Research·D AlewijnseB van den Borne
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Peggy A NortonUNKNOWN Duloxetine Urinary Incontinence Study Group
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Matthew D BarberKimberly W Coates
Apr 23, 2003·Neurourology and Urodynamics·Pauline ChiarelliJill Cockburn
Jul 16, 2003·American Journal of Obstetrics and Gynecology·Ilker Yalcin, Richard C Bump
Sep 23, 2003·The Journal of Urology·Roger R DmochowskiUNKNOWN Duloxetine Urinary Incontinence Study Group
Feb 7, 2004·BJU International·R J MillardUNKNOWN Duloxetine UI Study Group
Feb 14, 2004·BJOG : an International Journal of Obstetrics and Gynaecology·Philip van KerrebroeckUNKNOWN Duloxetine Urinary Incontinence Study Group
Mar 12, 2004·International Urogynecology Journal and Pelvic Floor Dysfunction·Kari Bø
Sep 2, 2004·Obstetrics and Gynecology·Linda CardozoRichard C Bump
Apr 12, 2005·The Journal of Urology·Gamal M GhoniemUNKNOWN Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group
May 3, 2005·Obstetrics and Gynecology·Kari BøIngrid Nygaard

❮ Previous
Next ❯

Citations

Mar 10, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Ulrich MehnertBrigitte Schurch
Aug 19, 2011·Current Urology Reports·Erin C ChongJennifer T Anger
Apr 2, 2010·International Journal of Epidemiology·Judith Mwansa-KambafwileJoy E Lawn
Mar 12, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Keith T PalmerUNKNOWN Faculty of Occupational Medicine
Mar 8, 2014·International Urogynecology Journal·Nadine Schwertner-TiepelmannRalf Tunn
Apr 25, 2007·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·P M LattheG Constantine
Nov 26, 2009·Current Medical Research and Opinion·Linda CardozoYan D Zhao
Apr 22, 2008·BJU International·Richard C BumpWei Chen
Feb 21, 2014·BMC Urology·Carsten FrohmeAxel Hegele
Nov 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·Alan Bowling
Apr 26, 2013·Autism : the International Journal of Research and Practice·Nirit Bauminger-ZvielyEynat Gal
Nov 4, 2015·The Cochrane Database of Systematic Reviews·Reuben Olugbenga AyelekeMuhammad Imran Omar
Jun 15, 2007·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Urogynecology Journal and Pelvic Floor Dysfunction
David Castro-DiazDuloxetine Dose Escalation Study Group
The Australian & New Zealand Journal of Obstetrics & Gynaecology
Hiu Lan FanTony Kwok Hung Chung
The Cochrane Database of Systematic Reviews
Paramananthan MariappanAmmar Alhasso
Revista da Associação Médica Brasileira
Fátima Faní FitzRodrigo Aquino Castro
© 2021 Meta ULC. All rights reserved